Results from a clinical trial showed that capivasertib plus the hormone therapy fulvestrant increased the time before the ...

The Institute of Cancer Research, London, which helped develop the drug, welcomed the move. | ITV National News ...

Listen to this article Mark T. Esser, vice president for vaccines and immune therapies at pharmaceutical giant AstraZeneca, will be the inaugural chief scientific officer and leader of the Paul and ...

Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.